Désolé, cet article est seulement disponible en EN.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Présentation
Projets
Publications
Télécharger-
2025Whose line is it anyway? Defining sero-positivity cut-offs for infectious disease surveillance., J Infect Dis 2025 Oct; (): .
-
2023Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021, Eurosurveillance, 2023, 28 (25), ⟨10.2807/1560-7917.ES.2023.28.25.2200681⟩.
-
2022Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
-
2022Declines in prevalence alter the optimal level of sexual investment for the malaria parasite Plasmodium falciparum, Proc Natl Acad Sci USA. 2022;119(30):e2122165119.
-
2022Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
-
2021Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 Nov; 224(9): 1489-1499.
-
2021Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats., Infect Genet Evol 2021 Sep; 93(): 104916.
-
2021Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection., J Clin Immunol 2021 Aug; (): .
-
2021Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
-
2021Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 May; 2(5): 100275.
-
+Voir la liste complète de publications